shutterstock_2032811501_edited_edited_edited.jpg

Developing novel therapeutics from
the kanna plant

About us

We are a preclinical stage company developing novel therapeutics inspired by kanna, or Sceletium tortuosum. Kanna is a medicinal succulent traditionally used by the San hunter-gatherers of South Africa. 

Our scientific research

Kanna has been extensively studied for decades, notably by our Chief Scientific Officer Dr Nigel Gericke. 

kanna.jpeg
 

Our team

nigel_edited

nigel_edited

IMG_2492 2_edited

IMG_2492 2_edited

headshot

headshot

lars compass_edited

lars compass_edited

John Boghossian (small)

John Boghossian (small)

Picture1

Picture1

Picture1

Picture1

Chris 3

Chris 3

F62A0034_edited

F62A0034_edited

Thomas Pfeiffer_edited

Thomas Pfeiffer_edited

LinkedIn profile pic_edited

LinkedIn profile pic_edited

raphprofile_edited

raphprofile_edited

Emma colour

Emma colour

We are a diverse team drawing on experience from the world of business and science, focused on bringing novel compounds, inspired by kanna, to patients in high unmet need indications.

Careers

We are currently hiring for permanent positions and internships year-round. Our headquarters are in London and we are a remote-friendly employer. We have team members across countries in Europe and North America.

Open positions:

Chief Medical Officer

To find out more, please contact careers@kanna.health

Thanks for submitting! We will review your message and contact you as soon as possible.